Christine Ott

Christine Ott, Ph.D., is the Associate Director of Ocular Preclinical Research at Roche, a position held since 2025. Previously, Christine held the role of Associate Director at Spark Therapeutics, Inc., where they contributed to advancements in ocular gene therapy. With a Ph.D. in Biochemistry from the University of Delaware and extensive experience leading cross-functional teams, Christine is dedicated to translating scientific research into therapies aimed at restoring vision for patients with retinal diseases. Throughout their career, Christine has demonstrated a commitment to innovation and collaboration in the field of gene therapy.